These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4060344)

  • 1. [The diversity of hepatic p-450 cytochromes: their role in chemical carcinogenesis].
    Anderson A; Waithe W; Labbé D; Affolter M; Labelle Y
    Union Med Can; 1985 Sep; 114(9):731-2. PubMed ID: 4060344
    [No Abstract]   [Full Text] [Related]  

  • 2. Human cytochromes P450: evolution, catalytic activities and interindividual variations in expression.
    Gonzalez FJ; Gelboin HV
    Prog Clin Biol Res; 1991; 372():11-20. PubMed ID: 1956910
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.
    Gonzalez FJ; Gelboin HV
    Drug Metab Rev; 1994; 26(1-2):165-83. PubMed ID: 8082563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic activation of chemical carcinogens by cytochrome P-450].
    Kawajiri K
    Tanpakushitsu Kakusan Koso; 1988 Feb; 33(2):167-73. PubMed ID: 3393690
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations.
    Yang CS; Smith TJ; Hong JY
    Cancer Res; 1994 Apr; 54(7 Suppl):1982s-1986s. PubMed ID: 8137324
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
    Villard PH; Seree EM; Re JL; De Meo M; Barra Y; Attolini L; Dumenil G; Catalin J; Durand A; Lacarelle B
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):195-204. PubMed ID: 9473526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects of the polymorphism of oxidation phenotype].
    Mrozikiewicz PM
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):608-10. PubMed ID: 1488339
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
    Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrahepatic carcinogenesis. Cytochrome P-450-dependent enzymes of the monoxygenase type are of major importance].
    Rydström J
    Lakartidningen; 1983 Nov; 80(48):4678-84. PubMed ID: 6664167
    [No Abstract]   [Full Text] [Related]  

  • 12. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 13. The 1988 Bernard B. Brodie Award lecture. Functional diversity of hepatic cytochromes P-450.
    Levin W
    Drug Metab Dispos; 1990; 18(6):824-30. PubMed ID: 1981523
    [No Abstract]   [Full Text] [Related]  

  • 14. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.
    Guengerich FP
    Cancer Res; 1988 Jun; 48(11):2946-54. PubMed ID: 3284639
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens.
    Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y
    Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver.
    DiMaio Knych HK; Stanley SD
    Biochem Pharmacol; 2008 Oct; 76(7):904-11. PubMed ID: 18692486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C
    Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
    Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
    Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility to toxic substances and its relationship to carcinogenesis.
    Hanke JZ
    IARC Sci Publ; 1984; (59):99-106. PubMed ID: 6336235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.